Related Experiment Video
Updated: Feb 14, 2026

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species
Xiangcheng Qing1, Zengwu Shao1, Xiao Lv1
1Departments of Orthopedics.
Abstract:
MTH1 has become a new rising star in the field of 'cancer phenotypic lethality' and can be targeted in many kinds of tumors. This study aimed to explore the anticancer effect of MTH1-targeted drug (S)-crizotinib on osteosarcoma (OS) cells. We detected MTH1 expression in OS tissues and cells using immunohistochemistry and western blot. The effects of MTH1 on OS cell viability were explored using the siRNA technique and CCK8. The anticancer effects of the MTH1-targeted drug (S)-crizotinib on OS cells were explored by in-vitro assays. The intracellular 8-oxo-dGTP level and oxygen reactive species (ROS) of OS cells were detected by Cy3-conjugated avidin staining and dichlorofluorescein diacetate staining, respectively. The expression of MTH1 was significantly higher in OS tissues and cell lines than that in the corresponding adjacent tissues and osteoblastic cell line. The proliferation of OS cells was significantly inhibited through knockdown of MTH1 by siRNA technology. (S)-Crizotinib could inhibit the proliferation of OS cells with an increase in the apoptosis levels and causing G0/G1 arrest by targeting MTH1 and activating ROS. In addition, (S)-crizotinib could inhibit the migration of OS cells. (S)-Crizotinib could suppress the proliferation and migration, cause G0/G1 arrest, and increase the apoptosis level of OS cells by targeting MTH1 and activating ROS. This study will provide a promising therapeutic target and the theoretical basis for the clinical application of (S)-crizotinib in OS.
Insights
MTH1 (mut Tpase 1) is highly expressed in osteosarcoma (OS). Targeting MTH1 with (S)-crizotinib inhibits OS cell proliferation and migration by activating reactive oxygen species (ROS).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- MTH1 (mut Tpase 1) is a key target in cancer therapy, particularly for 'cancer phenotypic lethality'.
- Osteosarcoma (OS) is a common bone cancer with limited treatment options, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the anticancer effects of the MTH1-targeted drug (S)-crizotinib on osteosarcoma (OS) cells.
- To explore the role of MTH1 expression in OS development and its potential as a therapeutic target.
Main Methods:
- Immunohistochemistry and western blot to detect MTH1 expression in OS tissues and cells.
- siRNA technology and CCK8 assays to assess MTH1's effect on OS cell viability.
- In-vitro assays to evaluate (S)-crizotinib's efficacy, including apoptosis, cell cycle arrest, and migration.
- Detection of intracellular 8-oxo-dGTP levels and reactive oxygen species (ROS) using specific staining methods.
Main Results:
- MTH1 expression was significantly elevated in OS tissues and cell lines compared to normal controls.
- Knockdown of MTH1 using siRNA suppressed OS cell proliferation.
- (S)-Crizotinib inhibited OS cell proliferation, induced apoptosis, caused G0/G1 cell cycle arrest, and suppressed migration.
- The anticancer effects of (S)-crizotinib were mediated by targeting MTH1 and activating ROS.
Conclusions:
- MTH1 is a promising therapeutic target for osteosarcoma.
- (S)-Crizotinib demonstrates significant anticancer potential against OS by modulating MTH1 and ROS.
- This study provides a strong theoretical basis for the clinical application of (S)-crizotinib in treating osteosarcoma.
Related Concept Videos
What is a Species?
Formation of Species
Keystone Species
Cross-reactivity
Reactivity of Enols
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

